2P2 mAb (Monash University)

N/A

Report date: 2025/01/26 18:31:03

Base Information

Drug Name2P2 mAb (Monash University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-21 stimulants
TargetsInterleukin-21
Therapy Area/IndicationsNeoplasmsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Active CompaniesMonash University
Inactive CompaniesN/A
Active IndicationsNeoplasmsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A